Related Experiment Video
Updated: Oct 31, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP
Kanako Nishiyama1,2, Masashi Maekawa3,4, Tomoya Nakagita5
1Department of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.
Abstract:
Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3/KCTD10 E3 complex, enabled CNKSR1 to interact with PTPRH at the plasma membrane resulting in inactivation of EGFR phosphatase activity. Depletion of CUL3 or KCTD10 led to the accumulation of RhoB-GTP at the plasma membrane followed by its interaction with CNKSR1, which released activated PTPRH from CNKSR1. This study suggests a mechanism of PTPRH activation through the exclusive binding of RhoB-GTP to CNKSR1.
Insights
Degradation of RhoB by CUL3/KCTD10 is crucial for HER2-positive breast cancer cell growth by regulating EGFR and HER2 phosphorylation. This finding offers a potential therapeutic target for HER2-positive breast cancers.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- HER2-positive breast cancer proliferation is driven by epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation.
- Targeting phosphatases for these receptors presents a potential therapeutic strategy.
Purpose of the Study:
- To investigate the role of RhoB degradation by the CUL3/KCTD10 complex in regulating EGFR and HER2 phosphorylation.
- To elucidate the mechanism by which RhoB influences phosphatase activity in HER2-positive breast cancer cells.
Main Methods:
- Utilized human protein arrays synthesized via a wheat cell-free system to identify protein interactions.
- Investigated the effects of CUL3 and KCTD10 depletion on RhoB and PTPRH localization and activity.
- Examined the interaction between RhoB-GTP, CNKSR1, and PTPRH.
Main Results:
- RhoB degradation by CUL3/KCTD10 is essential for EGFR and HER2 phosphorylation.
- CNKSR1 interaction with PTPRH, leading to EGFR phosphatase inactivation, is enabled by RhoB degradation.
- Depletion of CUL3 or KCTD10 causes RhoB-GTP accumulation, leading to PTPRH activation.
Conclusions:
- A novel mechanism for PTPRH activation via RhoB-GTP binding to CNKSR1 is proposed.
- The CUL3/KCTD10-RhoB pathway is critical for maintaining EGFR and HER2 phosphorylation in HER2-positive breast cancer.
- This pathway represents a potential therapeutic target for HER2-positive breast cancers.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases
MAPK Signaling Cascades
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade

